Unlimited Vision, Real Opportunities Icosystem logo
about us
about us
technology
technology
methodology
methodology
applications
applications
publications
News and Articles
News and Articles
Scientific Papers
News and Articles
careers
contact us
site map
search


Icosystem's CEO co-authors HBR article "A More Rational Approach to New-Product Development"
Icosystem Corporation Press Release
Cambridge, MA - 01 March 2008

A full copy of the article is available for purchase from the HBR web site.

Overview

Companies often treat new-product development as a monolithic process, but it can be more rationally divided into two parts: an early stage that focuses on evaluating prospects and eliminating bad bets, and a late stage that maximizes the remaining candidates' market potential. Recognizing the value of this approach, Eli Lilly designed and piloted Chorus, an autonomous unit dedicated solely to the early stage. This article demonstrates how segmenting development in this way can speed it up and make it more cost-effective. Two classes of decision-making errors can impede NPD, the authors say. First, managers often ignore evidence challenging their assumptions that projects will succeed. As a result, many projects go forward despite multiple red flags; some even reach the market, only to fail dramatically after their introduction. Second, companies sometimes terminate projects prematurely because people fail to conduct the right experiments to reveal products' potential. Most companies promote both kinds of errors by focusing disproportionately on late-stage development; they lack the early, truth-seeking functions that would head such errors off. In segmented NPD, however, the early-stage organization maintains loyalty to the experiment rather than the product, whereas the late-stage organization pursues commercial success. Chorus has significantly improved NPD efficiency and productivity at Lilly. Although the unit absorbs just one-tenth of Lilly's investment in early-stage development, it delivers a substantially greater fraction of the molecules slated for late Phase II trials--at almost twice the speed and less than a third of the cost of the standard process, sometimes shaving as much as two years off the usual development time.

About Icosystem Corporation

Icosystem Corporation, a strategy consulting firm in Cambridge, Massachusetts, has emerged as a leader in the development of business applications for network theory and complexity science. Using the tools of complexity science and advanced computational techniques, Icosystem provides a highly flexible and cost-effective technology platform for exploring business problems and discovering or designing strategies that have significant impact. Icosystem's approach uses realistic models of complex business environments and evolutionary and distributed computational techniques to validate new business ventures or improve the performance of existing enterprises.

Copyright 2002, Icosystem Corporation. All Rights Reserved.
home - about us - technology - methodology - applications - publications
site home info@icosystem.com